Kamada (KMDA) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Kamada Gets $25 Million Contract to Supply Kamrab, Varizig in Latin America; Shares Rise
MT NewswiresJan 22 10:01 ET
Express News | Kamada Announces a $25 Million 3-Year Contract for Supply of Kamrab® and Varizig® in Latin America
ReutersJan 22 07:00 ET
Stifel Maintains Kamada(KMDA.US) With Buy Rating
Moomoo NewsJan 8 18:32 ET · Ratings
Stifel Nicolaus Reaffirms Their Buy Rating on Kamada (KMDA)
TipRanksJan 8 18:08 ET · Ratings
Kamada Up Nearly 14%, on Track for Highest Close Since February 2021 -- Data Talk
Dow JonesJan 8 14:38 ET
Kamada Shares Rise 16% on Earnings Outlook, Trial Progress
WSJJan 8 14:06 ET

Comments

EC2025

14 hours ago

$Kamada (KMDA.US)$ Recent Developments: 🚀🚀🚀🚀👀
• Financial Guidance for 2025: On January 8, 2025, Kamada affirmed its 2024 financial guidance, expecting revenues between $158 million and $162 million, and adjusted EBITDA between $32 million and $35 million. For 2025, the company forecasts revenues between $178 million and $182 million, and adjusted EBITDA between $38 million and $42 million, representing a 13% increase in revenues and a 19% increase in adjusted EBITDA based on the mid-point of ...

Jaguar8

Jan 22 23:28

🟤 Watchlist, JANUARY 23,2025, Thursday. NFA

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
8. With regards t...

61

17

9

Jaguar8

Jan 22 06:06

NEWS

$Kamada (KMDA.US)$
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
Kamada (NASDAQ: KMDA) has secured a significant $25 million contract for supplying KAMRAB® and VARIZIG® in Latin America over a three-year period from 2025-2027. This contract with an international organization reinforces Kamada's position in the specialty plasma-derived field.
KAMRAB is used for post-exposure prevention of rabies infection, while VARIZIG is indicated for pos...

1

Trytosaveabit

Jan 22 06:02

news

$Kamada (KMDA.US)$ Reuters
1 min ago
Kamada Announces a $25 Million 3-Year Contract for Supply of Kamrab® and Varizig® in Latin America

1

Trytosaveabit

Jan 8 06:25

Update

$Kamada (KMDA.US)$ Kamada: FDA Agrees With Error Control Rate Change for Phase 3 Trial for Alpha-1 Antitrypsin >KMDA.TA.TV
Dow Jones· 4 mins ago

KMDA Kamada

Trade Overview

Capital Trend

News

Comments

Trending Stocks